ezetimibe

Generic: ezetimibe

Labeler: ascend laboratories, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name ezetimibe
Generic Name ezetimibe
Labeler ascend laboratories, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ezetimibe 10 mg/1

Manufacturer
Ascend Laboratories, LLC

Identifiers & Regulatory

Product NDC 67877-490
Product ID 67877-490_878751ea-5bea-42ef-8f56-2b15a683c7ae
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA209234
Listing Expiration 2026-12-31
Marketing Start 2017-12-23

Pharmacologic Class

Established (EPC)
dietary cholesterol absorption inhibitor [epc]
Physiologic Effect
decreased cholesterol absorption [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 67877490
Hyphenated Format 67877-490

Supplemental Identifiers

RxCUI
349556
UNII
EOR26LQQ24
NUI
N0000008553 N0000175911

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name ezetimibe (source: ndc)
Generic Name ezetimibe (source: ndc)
Application Number ANDA209234 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 10 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (67877-490-01)
  • 500 TABLET in 1 BOTTLE (67877-490-05)
  • 30 TABLET in 1 BOTTLE (67877-490-30)
  • 5000 TABLET in 1 BOTTLE (67877-490-55)
  • 90 TABLET in 1 BOTTLE (67877-490-90)
source: ndc

Packages (5)

67877-490-01 100 TABLET in 1 BOTTLE (67877-490-01) 67877-490-05 500 TABLET in 1 BOTTLE (67877-490-05) 67877-490-30 30 TABLET in 1 BOTTLE (67877-490-30) 67877-490-55 5000 TABLET in 1 BOTTLE (67877-490-55) 67877-490-90 90 TABLET in 1 BOTTLE (67877-490-90)

Ingredients (1)

ezetimibe (10 mg/1)

Linked Drug Pages (1)

Ezetimibe ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "878751ea-5bea-42ef-8f56-2b15a683c7ae", "openfda": {"nui": ["N0000008553", "N0000175911"], "unii": ["EOR26LQQ24"], "rxcui": ["349556"], "spl_set_id": ["206d702c-b09a-4555-972b-6555d6d6d6e6"], "pharm_class_pe": ["Decreased Cholesterol Absorption [PE]"], "pharm_class_epc": ["Dietary Cholesterol Absorption Inhibitor [EPC]"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (67877-490-01)", "package_ndc": "67877-490-01", "marketing_start_date": "20171223"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (67877-490-05)", "package_ndc": "67877-490-05", "marketing_start_date": "20171223"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (67877-490-30)", "package_ndc": "67877-490-30", "marketing_start_date": "20171223"}, {"sample": false, "description": "5000 TABLET in 1 BOTTLE (67877-490-55)", "package_ndc": "67877-490-55", "marketing_start_date": "20171223"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (67877-490-90)", "package_ndc": "67877-490-90", "marketing_start_date": "20171223"}], "brand_name": "Ezetimibe", "product_id": "67877-490_878751ea-5bea-42ef-8f56-2b15a683c7ae", "dosage_form": "TABLET", "pharm_class": ["Decreased Cholesterol Absorption [PE]", "Dietary Cholesterol Absorption Inhibitor [EPC]"], "product_ndc": "67877-490", "generic_name": "Ezetimibe", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ezetimibe", "active_ingredients": [{"name": "EZETIMIBE", "strength": "10 mg/1"}], "application_number": "ANDA209234", "marketing_category": "ANDA", "marketing_start_date": "20171223", "listing_expiration_date": "20261231"}